Etonoges vagin ring 3S
Ended Awarded
- Contract number
- SPE2DR26FBTDA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,912
Award facts
- Contract value 100% obligated
- $4,912.32 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,912.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 14, 2025, represents one of numerous orders placed under DMS Pharmaceutical Group's newly awarded Indefinite Delivery Contract (IDC) with the Defense Logistics Agency. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group has been registered in the System for Award Management since 2001 and maintains consistent performance as a critical pharmaceutical supplier to Department of Defense healthcare operations.
This delivery order falls under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy through which DMS Pharmaceutical Group holds a single-award IDC valued at $499,999,999 and extending through December 31, 2036. Under this prime vendor contract structure, the Defense Logistics Agency issues firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's extensive product portfolio encompasses oncology treatments, immunosuppressants, specialty pharmaceuticals, and routine medications, positioning the company as a key supplier within the federal pharmaceutical supply chain for Department of Defense operations globally.
Quick answers
Who was awarded contract SPE2DR26FBTDA?
SPE2DR26FBTDA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FBTDA worth?
The government has obligated $4,912 on SPE2DR26FBTDA.
Is contract SPE2DR26FBTDA an order under another contract?
Yes. SPE2DR26FBTDA is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTDA competed?
The extent of competition for SPE2DR26FBTDA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award